The same results will likely be obtained for fludarabine treatment of CLL, as MMP9 is increased in CLL cells under the influence of fludarabine treatment, and this increase could be mediated by HO-1. Here, HMOX1 is linked to B-cell chronic lymphocytic leukemia.